Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 16 studies | 55% ± 19% | |
astrocyte | 3 studies | 19% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 7 studies | 30% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 11375.05 | 2585 / 2642 | 94% | 149.84 | 663 / 705 |
ovary | 94% | 3054.67 | 170 / 180 | 60% | 7.27 | 260 / 430 |
thymus | 9% | 63.88 | 62 / 653 | 63% | 8.78 | 379 / 605 |
adrenal gland | 6% | 45.12 | 16 / 258 | 19% | 4.69 | 44 / 230 |
skin | 0% | 1.01 | 2 / 1809 | 22% | 10.75 | 106 / 472 |
breast | 1% | 4.05 | 3 / 459 | 22% | 1.32 | 243 / 1118 |
eye | 0% | 0 | 0 / 0 | 18% | 1.26 | 14 / 80 |
spleen | 12% | 97.50 | 30 / 241 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 12% | 0.93 | 104 / 901 |
uterus | 2% | 15.19 | 4 / 170 | 5% | 0.54 | 22 / 459 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.49 | 1 / 29 |
lung | 0% | 0 | 0 / 578 | 2% | 0.07 | 20 / 1155 |
esophagus | 0% | 4.70 | 5 / 1445 | 1% | 0.04 | 2 / 183 |
blood vessel | 1% | 10.26 | 19 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0 | 0 / 328 | 1% | 0.03 | 2 / 178 |
adipose | 1% | 6.64 | 12 / 1204 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 1% | 0.05 | 5 / 504 |
heart | 0% | 2.72 | 4 / 861 | 0% | 0 | 0 / 0 |
prostate | 0% | 2.35 | 1 / 245 | 0% | 0 | 0 / 502 |
stomach | 0% | 0 | 0 / 359 | 0% | 0.03 | 1 / 286 |
intestine | 0% | 0 | 0 / 966 | 0% | 0.00 | 1 / 527 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0098742 | Biological process | cell-cell adhesion via plasma-membrane adhesion molecules |
GO_0031103 | Biological process | axon regeneration |
GO_0071260 | Biological process | cellular response to mechanical stimulus |
GO_0048711 | Biological process | positive regulation of astrocyte differentiation |
GO_0032289 | Biological process | central nervous system myelin formation |
GO_0007155 | Biological process | cell adhesion |
GO_0045665 | Biological process | negative regulation of neuron differentiation |
GO_0010977 | Biological process | negative regulation of neuron projection development |
GO_0030517 | Biological process | negative regulation of axon extension |
GO_0019226 | Biological process | transmission of nerve impulse |
GO_0031643 | Biological process | positive regulation of myelination |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0043209 | Cellular component | myelin sheath |
GO_0005886 | Cellular component | plasma membrane |
GO_0045121 | Cellular component | membrane raft |
GO_0043220 | Cellular component | Schmidt-Lanterman incisure |
GO_0033270 | Cellular component | paranode region of axon |
GO_0097453 | Cellular component | mesaxon |
GO_0043218 | Cellular component | compact myelin |
GO_0035749 | Cellular component | myelin sheath adaxonal region |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0033691 | Molecular function | sialic acid binding |
GO_1905576 | Molecular function | ganglioside GT1b binding |
GO_0019901 | Molecular function | protein kinase binding |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0005102 | Molecular function | signaling receptor binding |
Gene name | MAG |
Protein name | Myelin-associated glycoprotein (Siglec-4a) Myelin associated glycoprotein |
Synonyms | GMA |
Description | FUNCTION: Adhesion molecule that mediates interactions between myelinating cells and neurons by binding to neuronal sialic acid-containing gangliosides and to the glycoproteins RTN4R and RTN4RL2 (By similarity). Not required for initial myelination, but seems to play a role in the maintenance of normal axon myelination. Protects motoneurons against apoptosis, also after injury; protection against apoptosis is probably mediated via interaction with neuronal RTN4R and RTN4RL2. Required to prevent degeneration of myelinated axons in adults; this probably depends on binding to gangliosides on the axon cell membrane (By similarity). Negative regulator of neurite outgrowth; in dorsal root ganglion neurons the inhibition is mediated primarily via binding to neuronal RTN4R or RTN4RL2 and to a lesser degree via binding to neuronal gangliosides. In cerebellar granule cells the inhibition is mediated primarily via binding to neuronal gangliosides. In sensory neurons, inhibition of neurite extension depends only partially on RTN4R, RTN4RL2 and gangliosides. Inhibits axon longitudinal growth (By similarity). Inhibits axon outgrowth by binding to RTN4R (By similarity). Preferentially binds to alpha-2,3-linked sialic acid. Binds ganglioside Gt1b (By similarity). . |
Accessions | ENST00000392213.8 [P20916-1] ENST00000597035.5 ENST00000600291.5 ENST00000537831.2 [P20916-3] ENST00000595791.5 M0R3I4 M0R3B9 P20916 M0QZU4 ENST00000361922.8 [P20916-2] |